Location History:
- Medfield, MA (US) (2002)
- Natick, MA (US) (2004)
Company Filing History:
Years Active: 2002-2004
Title: Innovator Spotlight: David Evans from Natick, MA
Introduction: David Evans is a prominent inventor based in Natick, Massachusetts, known for his groundbreaking contributions to molecular screening technologies. With a remarkable portfolio of two patents, Evans has made significant strides in enhancing the efficiency of ligand selection processes.
Latest Patents: David Evans' latest invention revolves around high-speed, automated, continuous flow, multi-dimensional molecular selection and analysis. This innovative method offers novel approaches for screening samples to select ligands targeted at specific molecules of interest. The process entails the combination of a heterogeneous solution of ligands with a target, allowing for selection based on binding characteristics. Ligands that exhibit the first binding characteristic form complexes with the target, which can then be separated from unbound components through various techniques, including size exclusion. Following this, the complex or unbound components are introduced to a second dimensional separation, effectively allowing for further refinement based on a secondary binding characteristic. Ultimately, this process elutes the ligand with the desired properties, representing a significant advancement in molecular analysis techniques.
Career Highlights: David Evans has showcased his dedication to innovation through his patent applications and the development of advanced methodologies in his field. Working at Perseptive Biosystems Inc., he has positioned himself as a key figure in the realm of automated molecular analysis, contributing to the enhancement of drug discovery and biochemistry research.
Collaborations: Throughout his career, David Evans has collaborated with notable colleagues in the industry, such as Satish Jindal and Kevin Williams. These partnerships illustrate the collaborative spirit within the innovative environment of Perseptive Biosystems Inc., fostering an atmosphere where cutting-edge inventions can come to fruition.
Conclusion: David Evans is a noteworthy inventor whose work in high-speed, automated molecular selection has the potential to significantly impact various scientific fields. His patents signify a deep commitment to advancing research methodologies, highlighting the importance of innovation in driving scientific progress. As he continues to develop new technologies, Evans remains a vital contributor to the advancement of molecular analysis.